Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Vachette, L. Nowak, X. Amouretti, B. Renaud, J. Bullier (1995)
In vitro study of the catecholaminergic metabolism of locus coeruleus neurones by differential normal pulse voltammetryJournal of Neuroscience Methods, 63
T. Dam, R. Quirion (1986)
Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brainPeptides, 7
A. Stoessl, David Hill (1990)
Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktideBrain Research, 534
C. Gardner, D. Armour, D. Beattie, J. Gale, A. Hawcock, Gavin Kilpatrick, D. Twissell, P. Ward (1996)
GR205171: A novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activityRegulatory Peptides, 65
N. Haddjeri, P. Blier (2000)
Effect of neurokinin‐1 receptor antagonists on the function of 5‐HT and noradrenaline neuronsNeuroReport, 11
S. Foote, F. Bloom, G. Aston-Jones (1983)
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity.Physiological reviews, 63 3
V. Pickel, T. Joh, D. Reis, S. Leeman, Richard Miller (1979)
Electron microscopic localization of substance P and enkephalin in axon terminals related to dendrites of catecholaminergic neuronsBrain Research, 160
P. Boden, G. Woodruff (1994)
Presence of NK3‐sensitive neurones in different proportions in the medial habenula of guinea‐pig, rat and gerbilBritish Journal of Pharmacology, 112
U. Wormser, R. Laufer, Y. Hart, M. Chorev, C. Gilon, Z. Selinger (1986)
Highly selective agonists for substance P receptor subtypes.The EMBO Journal, 5
T. Dam, E. Escher, R. Quirion (1990)
Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktideBrain Research, 506
M. Hahn, M. Bannon (1999)
Stress-induced c-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activationNeuroscience, 94
J. Yip, L. Chahl (1997)
Localization of Fos‐like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea‐pig brainBritish Journal of Pharmacology, 122
J. Beaujouan, M. Saffroy, Y. Torrens, J. Glowinski (2000)
Different Subtypes of Tachykinin NK1 Receptor Binding Sites Are Present in the Rat BrainJournal of Neurochemistry, 75
M. Millan, F. Lejeune, G. Nanteuil, A. Gobert (2001)
Selective blockade of neurokinin (NK)1 receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in ratsJournal of Neurochemistry, 76
G. Schmid, F. Carità, G. Bonanno, M. Raiteri (1998)
NK‐3 receptors mediate enhancement of substance P release from capsaicin‐sensitive spinal cord afferent terminalsBritish Journal of Pharmacology, 125
R. Steinberg, D. Rodier, J. Souilhac, I. Bougault, X. Emonds-alt, P. Soubrié, G. Fur (1995)
Pharmacological Characterization of Tachykinin Receptors Controlling Acetylcholine Release from Rat Striatum: An In Vivo Microdialysis StudyJournal of Neurochemistry, 65
X. Emonds-alt, D. Bichon, J. Ducoux, M. Héaulme, B. Miloux, M. Poncelet, V. Proietto, D. Broeck, P. Vilain, G. Néliat (1994)
SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.Life sciences, 56 1
A. Ciucci, C. Palma, S. Manzini, Thomas Werge (1998)
Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septideBritish Journal of Pharmacology, 125
J. Beaujouan, M. Saffroy, Y. Torrens, J. Glowinski (1997)
Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.European journal of pharmacology, 319 2-3
P. Guyenet, E. Mroz, G. Aghajanian, S. Leeman (1979)
Delayed iontophoretic ejection of substance P from glass micropipettes: Correlation with time-course of neuronal excitation in vivoNeuropharmacology, 18
S. Mclean, A. Ganong, P. Seymour, D. Bryce, R. Crawford, J. Morrone, L. Reynolds, Anne Schmidt, S. Zorn, J. Watson, A. Fossa, M. Depasquale, T. Rosen, A. Nagahisa, M. Tsuchiya, J. Heym (1996)
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.The Journal of pharmacology and experimental therapeutics, 277 2
M. Saffroy, J. Beaujouan, Y. Torrens, Jeanine Besseyre, L. Bergström, J. Glowinski (1988)
Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brainPeptides, 9
C. Humpel, A. Saria (1993)
Characterization of neurokinin binding sites in rat brain membranes using highly selective ligandsNeuropeptides, 25
Liang-Wei Chen, Li-Chun Wei, Huiling Liu, Z. Rao (2000)
Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the ratBrain Research, 873
B. Scatton, L. Rouquier, F. Javoy‐Agid, Y. Agid (1982)
Dopamine deficiency in the cerebral cortex in Parkinson diseaseNeurology, 32
C. Gueudet, V. Santucci, P. Soubrié, G. Fur (1999)
Blockade of neurokinin3 receptors antagonizes drug‐induced population response and depolarization block of midbrain dopamine neurons in guinea pigsSynapse, 33
C. Whitty, P. Walker, D. Goebel, M. Poosch, M. Bannon (1995)
Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigraNeuroscience, 64
I. Merchenthaler, J. Maderdrut, F. O’Harte, J. Conlon (1992)
Localization of neurokinin B in the central nervous system of the ratPeptides, 13
P. Guyenet, G. Aghajanian (1977)
Excitation of neurons in the nucleus locus coeruleus by substance P and related peptidesBrain Research, 136
Yu-Qiang Ding, R. Shigemoto, M. Takada, H. Ohishi, S. Nakanishi, N. Mizuno (1996)
Localization of the neuromedin K receptor (NK3) in the central nervous system of the ratJournal of Comparative Neurology, 364
S. Mclean, A. Ganong, P. Seymour, R. Snider, M. Desai, T. Rosen, D. Bryce, K. Longo, L. Reynolds, G. Robinson (1993)
Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.The Journal of pharmacology and experimental therapeutics, 267 1
R. Steinberg, J. Souilhac, D. Rodier, R. Alonso, X. Emonds-alt, G. Fur, P. Soubrié (1998)
Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activationNeuroscience, 84
P. Shughrue, M. Lane, I. Merchenthaler (1996)
In situ hybridization analysis of the distribution of neurokinin‐3 mRNA in the rat central nervous systemJournal of Comparative Neurology, 372
G. Seabrook, M. Main, Z. Razzaque, J. Longmore (1993)
Differences in the effects of tachykinin NK1 receptor antagonists: neuronal versus smooth muscle tissues.European journal of pharmacology, 250 1
C. Mussap, D. Geraghty, E. Burcher (1993)
Tachykinin Receptors: A Radioligand Binding PerspectiveJournal of Neurochemistry, 60
M. Warden, W. Young (1988)
Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous systemJournal of Comparative Neurology, 272
H. Cheeseman, R. Pinnock, G. Henderson (1983)
Substance P excitation of rat locus coeruleus neurones.European journal of pharmacology, 94 1-2
N. Marco, A. Thirion, G. Mons, I. Bougault, G. Fur, P. Soubrié, R. Steinberg (1998)
Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pigNeuropeptides, 32
M. Buda, G. Simoni, F. Gonon, J. Pujol (1983)
Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry. I. Nature and origin of contributors to the oxidation current at +0.1vBrain Research, 273
B. Velimirovic, K. Koyano, S. Nakajima, Y. Nakajima (1995)
Opposing mechanisms of regulation of a G-protein-coupled inward rectifier K+ channel in rat brain neurons.Proceedings of the National Academy of Sciences of the United States of America, 92
Catherine Ortemann, F. Robert, B. Renaud, L. Lambás-señas (1993)
In Vivo Microdialysis Study of the Extracellular 3,4‐Dihydroxyphenylacetic Acid in the Rat Locus Ceruleus: Topographical and Pharmacological AspectsJournal of Neurochemistry, 61
K. Shen, R. North (1992)
Substance P opens cation channels and closes potassium channels in rat locus coeruleus neuronsNeuroscience, 50
S. Guard, S. Watson, J. Maggio, H. Too, K. Watling (1990)
Pharmacological analysis of [3H]‐senktide binding to NK3 tachykinin receptors in guinea‐pig ileum longitudinal muscle‐myenteric plexus and cerebral cortex membranesBritish Journal of Pharmacology, 99
M. Kramer, N. Cutler, J. Feighner, R. Shrivastava, J. Carman, J. Sramek, S. Reines, Guanghan Liu, D. Snavely, E. Wyatt-Knowles, J. Hale, S. Mills, M. Maccoss, C. Swain, Timothy Harrison, R. Hill, F. Hefti, E. Scolnick, M. Cascieri, G. Chicchi, S. Sadowski, A. Williams, L. Hewson, David Smith, E. Carlson, R. Hargreaves, N. Rupniak (1998)
Distinct mechanism for antidepressant activity by blockade of central substance P receptors.Science, 281 5383
D. Mileusnic, J.M Lee, D. Magnuson, M. Hejna, J. Krause, J. Lorens, S. Lorens (1999)
Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical studyNeuroscience, 89
C. Shults, R. Quirion, B. Chronwall, T. Chase, T. O'Donohue (1984)
A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous systemPeptides, 5
J. Polley, P. Gaskin, M. Perren, H. Connor, P. Ward, D. Beattie (1997)
The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular systemRegulatory Peptides, 68
M. Jung, J. Michaud, R. Steinberg, M. Barnouin, A. Hayar, G. Mons, J. Souilhac, X. Emonds-alt, P. Soubrié, G. Fur (1996)
Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin receptor stimulationNeuroscience, 74
The present experiments investigated the role of neurokinin‐1 (NK1) and neurokinin‐3 (NK3) receptors on the activity of the locus coeruleus (LC)‐noradrenergic system by using a dual probe microdialysis technique in anesthetized guinea pigs. The local application in the LC of the selective NK1 receptor agonists [SAR9,Met(O2)11]‐SP (10 μM) and septide (1 μM) as well as the selective NK3 receptor agonist senktide (1 μM), enhanced the extracellular norepinephrine (NE) levels in the prefrontal cortex. The enhancing effect of [SAR9,Met(O2)11]‐SP was completely blocked by the peripheral administration of the selective non peptide NK1 and NK3 receptor antagonists, GR 205171 (1 mg/kg, i.p.) and SR 142801 (0.1 mg/kg, i.p.), respectively, whereas SR 142806 (0.1 mg/kg, i.p.) the inactive enantiomer of SR 142801 had no effect. Moreover, the [SAR9,Met(O2)11]‐SP‐induced increase in LC DOPAC concentrations, is only antagonized by GR 205171. In contrast, only SR 142801 (0.3 mg/kg, i.p.) could block stereoselectively the senktide‐evoked increase in NE levels. Both [SAR9,Met(O2)11]‐SP and senktide effects were blocked by local infusion into the LC of SR 142801 (10−9 M). These results demonstrate that stimulation of NK1 and NK3 receptors located in the LC area modulates the activity of the LC‐NE system, and that the excitatory effects of NK1 receptor agonists require NKB/NK3 receptor activation in the LC. Synapse 43:62–69, 2002. © 2001 Wiley‐Liss, Inc.
Synapse – Wiley
Published: Jan 1, 2002
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.